-transparent.png){kind=logo}
The binding of taxol to human plasma and to individual plasma proteins was studied by equilibrium dialysis. Taxol was found to bind extensively (about 95%) without a significant difference between healthy volunteers and cancer patients. At clinically relevant concentrations (0.1-6 microM), the binding was found to be concentration independent, indicating nonspecific hydrophobic binding. Human serum albumin and alpha 1-acid glycoprotein were found to contribute about equally to the binding, with a minor contribution from lipoproteins. None of the drugs commonly coadministered with taxol (dexamethasone, diphenhydramine, ranitidine, doxorubicin, 5-fluorouracil and cisplatin) altered the binding of taxol significantly. The protein binding of taxol was found to dramatically decrease the red blood cell uptake of taxol.
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
December 1983,
Clinical pharmacology and therapeutics,
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
March 1991,
International journal of clinical pharmacology, therapy, and toxicology,
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
October 1992,
The Journal of pharmacy and pharmacology,
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
October 2023,
Chirality,
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
March 1984,
Clinical pharmacology and therapeutics,
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
January 1989,
DICP : the annals of pharmacotherapy,
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
January 1984,
The Journal of pharmacy and pharmacology,
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
November 1987,
Biochemical pharmacology,
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
February 1991,
Biochemical pharmacology,
G N Kumar, and
U K Walle, and
K N Bhalla, and
T Walle
October 1989,
The Journal of pharmacy and pharmacology,
